nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—SLC18A2—Parkinson's disease	0.558	0.655	CbGaD
Tetrabenazine—DRD2—Parkinson's disease	0.172	0.202	CbGaD
Tetrabenazine—CYP2D6—Parkinson's disease	0.122	0.143	CbGaD
Tetrabenazine—SLC18A2—adrenal medulla—Parkinson's disease	0.0154	0.263	CbGeAlD
Tetrabenazine—SLC18A2—telencephalic ventricle—Parkinson's disease	0.00613	0.105	CbGeAlD
Tetrabenazine—DRD2—telencephalic ventricle—Parkinson's disease	0.00341	0.0584	CbGeAlD
Tetrabenazine—DRD2—nerve—Parkinson's disease	0.00215	0.0368	CbGeAlD
Tetrabenazine—CBR1—forebrain—Parkinson's disease	0.00186	0.0319	CbGeAlD
Tetrabenazine—SLC18A2—brainstem—Parkinson's disease	0.00166	0.0284	CbGeAlD
Tetrabenazine—Donepezil—HTR2A—Parkinson's disease	0.00163	0.522	CrCbGaD
Tetrabenazine—DRD2—hindbrain—Parkinson's disease	0.00161	0.0276	CbGeAlD
Tetrabenazine—SLC18A2—forebrain—Parkinson's disease	0.0016	0.0274	CbGeAlD
Tetrabenazine—CBR1—cardiovascular system—Parkinson's disease	0.00157	0.027	CbGeAlD
Tetrabenazine—Donepezil—CYP2D6—Parkinson's disease	0.00149	0.478	CrCbGaD
Tetrabenazine—CBR1—medulla oblongata—Parkinson's disease	0.00135	0.0231	CbGeAlD
Tetrabenazine—CBR1—midbrain—Parkinson's disease	0.00123	0.0211	CbGeAlD
Tetrabenazine—CBR1—spinal cord—Parkinson's disease	0.0012	0.0206	CbGeAlD
Tetrabenazine—SLC18A2—medulla oblongata—Parkinson's disease	0.00116	0.0198	CbGeAlD
Tetrabenazine—CBR1—head—Parkinson's disease	0.00107	0.0183	CbGeAlD
Tetrabenazine—SLC18A2—midbrain—Parkinson's disease	0.00106	0.0181	CbGeAlD
Tetrabenazine—CBR1—nervous system—Parkinson's disease	0.00101	0.0173	CbGeAlD
Tetrabenazine—CBR1—central nervous system—Parkinson's disease	0.000973	0.0167	CbGeAlD
Tetrabenazine—CYP2D6—hindbrain—Parkinson's disease	0.000967	0.0166	CbGeAlD
Tetrabenazine—CBR1—cerebellum—Parkinson's disease	0.000951	0.0163	CbGeAlD
Tetrabenazine—DRD2—brainstem—Parkinson's disease	0.000922	0.0158	CbGeAlD
Tetrabenazine—SLC18A2—head—Parkinson's disease	0.000917	0.0157	CbGeAlD
Tetrabenazine—DRD2—forebrain—Parkinson's disease	0.00089	0.0153	CbGeAlD
Tetrabenazine—SLC18A2—nervous system—Parkinson's disease	0.000869	0.0149	CbGeAlD
Tetrabenazine—SLC18A2—central nervous system—Parkinson's disease	0.000837	0.0143	CbGeAlD
Tetrabenazine—SLC18A2—cerebellum—Parkinson's disease	0.000818	0.014	CbGeAlD
Tetrabenazine—CBR1—brain—Parkinson's disease	0.000773	0.0132	CbGeAlD
Tetrabenazine—SLC18A2—brain—Parkinson's disease	0.000664	0.0114	CbGeAlD
Tetrabenazine—SLC18A2—Neurotransmitter Release Cycle—MAOA—Parkinson's disease	0.000631	0.00728	CbGpPWpGaD
Tetrabenazine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00063	0.00727	CbGpPWpGaD
Tetrabenazine—CYP2D6—CYP2E1 reactions—CYP2E1—Parkinson's disease	0.000626	0.00722	CbGpPWpGaD
Tetrabenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—TH—Parkinson's disease	0.000623	0.00719	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—NQO1—Parkinson's disease	0.000601	0.00694	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—HSPA1A—Parkinson's disease	0.000597	0.00689	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—SLC6A3—Parkinson's disease	0.000593	0.00684	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.000588	0.00679	CbGpPWpGaD
Tetrabenazine—DRD2—midbrain—Parkinson's disease	0.000588	0.0101	CbGeAlD
Tetrabenazine—CYP2D6—brainstem—Parkinson's disease	0.000554	0.0095	CbGeAlD
Tetrabenazine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—Parkinson's disease	0.000537	0.0062	CbGpPWpGaD
Tetrabenazine—CYP2D6—forebrain—Parkinson's disease	0.000535	0.00917	CbGeAlD
Tetrabenazine—DRD2—head—Parkinson's disease	0.00051	0.00874	CbGeAlD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.000508	0.00586	CbGpPWpGaD
Tetrabenazine—DRD2—Monoamine GPCRs—HTR1A—Parkinson's disease	0.000504	0.00582	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—GSTP1—Parkinson's disease	0.000501	0.00579	CbGpPWpGaD
Tetrabenazine—DRD2—Hypothetical Network for Drug Addiction—DRD1—Parkinson's disease	0.000499	0.00576	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—HMOX1—Parkinson's disease	0.000495	0.00571	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000488	0.00563	CbGpPWpGaD
Tetrabenazine—DRD2—Monoamine GPCRs—DRD1—Parkinson's disease	0.000487	0.00562	CbGpPWpGaD
Tetrabenazine—DRD2—nervous system—Parkinson's disease	0.000483	0.00829	CbGeAlD
Tetrabenazine—DRD2—Monoamine GPCRs—DRD3—Parkinson's disease	0.000472	0.00544	CbGpPWpGaD
Tetrabenazine—DRD2—central nervous system—Parkinson's disease	0.000465	0.00798	CbGeAlD
Tetrabenazine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.000464	0.00535	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—GSTM1—Parkinson's disease	0.000461	0.00532	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—HGF—Parkinson's disease	0.000461	0.00532	CbGpPWpGaD
Tetrabenazine—DRD2—cerebellum—Parkinson's disease	0.000455	0.0078	CbGeAlD
Tetrabenazine—DRD2—Hypothetical Network for Drug Addiction—GRIN2B—Parkinson's disease	0.000451	0.00521	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—KCNJ4—Parkinson's disease	0.000451	0.0052	CbGpPWpGaD
Tetrabenazine—DRD2—Monoamine GPCRs—HTR7—Parkinson's disease	0.000426	0.00492	CbGpPWpGaD
Tetrabenazine—DRD2—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.000424	0.00489	CbGpPWpGaD
Tetrabenazine—DRD2—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.000409	0.00472	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000397	0.00458	CbGpPWpGaD
Tetrabenazine—DRD2—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.000396	0.00457	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—DLG1—Parkinson's disease	0.000389	0.00449	CbGpPWpGaD
Tetrabenazine—CYP2D6—Xenobiotics—CYP2E1—Parkinson's disease	0.000388	0.00447	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—Parkinson's disease	0.000383	0.00442	CbGpPWpGaD
Tetrabenazine—CYP2D6—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000373	0.0043	CbGpPWpGaD
Tetrabenazine—DRD2—brain—Parkinson's disease	0.000369	0.00633	CbGeAlD
Tetrabenazine—DRD2—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.000359	0.00414	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000338	0.0039	CbGpPWpGaD
Tetrabenazine—CYP2D6—head—Parkinson's disease	0.000306	0.00525	CbGeAlD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000304	0.00351	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—GRIK1—Parkinson's disease	0.000304	0.00351	CbGpPWpGaD
Tetrabenazine—DRD2—Monoamine GPCRs—HTR2A—Parkinson's disease	0.000299	0.00345	CbGpPWpGaD
Tetrabenazine—CYP2D6—nervous system—Parkinson's disease	0.00029	0.00498	CbGeAlD
Tetrabenazine—CBR1—Metabolism—MCCC1—Parkinson's disease	0.000287	0.00331	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ND3—Parkinson's disease	0.000287	0.00331	CbGpPWpGaD
Tetrabenazine—CYP2D6—central nervous system—Parkinson's disease	0.00028	0.00479	CbGeAlD
Tetrabenazine—CYP2D6—cerebellum—Parkinson's disease	0.000273	0.00468	CbGeAlD
Tetrabenazine—CBR1—Metabolism—TALDO1—Parkinson's disease	0.000269	0.00311	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—OMD—Parkinson's disease	0.000269	0.00311	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000259	0.00299	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—GRIK2—Parkinson's disease	0.000259	0.00299	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—NDUFB11—Parkinson's disease	0.000255	0.00295	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000254	0.00293	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000254	0.00293	CbGpPWpGaD
Tetrabenazine—DRD2—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.000251	0.0029	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.000244	0.00282	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GCH1—Parkinson's disease	0.000244	0.00281	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000241	0.00278	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000237	0.00274	CbGpPWpGaD
Tetrabenazine—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000237	0.00273	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000223	0.00257	CbGpPWpGaD
Tetrabenazine—CYP2D6—brain—Parkinson's disease	0.000222	0.00381	CbGeAlD
Tetrabenazine—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000221	0.00255	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00022	0.00254	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000218	0.00251	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—FBP1—Parkinson's disease	0.000217	0.00251	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GBA—Parkinson's disease	0.000217	0.00251	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—DBH—Parkinson's disease	0.000217	0.00251	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000215	0.00248	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000206	0.00238	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—CHRNA4—Parkinson's disease	0.000198	0.00229	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000192	0.00222	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—DDC—Parkinson's disease	0.000183	0.00212	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000182	0.0021	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—HSPA8—Parkinson's disease	0.000182	0.0021	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000181	0.00209	CbGpPWpGaD
Tetrabenazine—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00018	0.00207	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—GRM4—Parkinson's disease	0.000176	0.00203	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.000174	0.00201	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—DLG4—Parkinson's disease	0.000171	0.00197	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—PENK—Parkinson's disease	0.000167	0.00193	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—GRIN2B—Parkinson's disease	0.000167	0.00192	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—SLC6A3—Parkinson's disease	0.000164	0.0019	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000161	0.00186	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—DDC—Parkinson's disease	0.000159	0.00184	CbGpPWpGaD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000159	0.00183	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—GPR37—Parkinson's disease	0.000157	0.00181	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—PDYN—Parkinson's disease	0.000153	0.00176	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTA4—Parkinson's disease	0.000151	0.00174	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000149	0.00172	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—COMT—Parkinson's disease	0.00014	0.00161	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—MAOA—Parkinson's disease	0.000139	0.0016	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.000137	0.00158	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PLA2G6—Parkinson's disease	0.000136	0.00156	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—MAOB—Parkinson's disease	0.000134	0.00155	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000133	0.00153	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000131	0.00151	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000128	0.00147	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000124	0.00143	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000122	0.0014	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—DRD1—Parkinson's disease	0.000115	0.00132	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000114	0.00132	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000113	0.0013	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000112	0.00129	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—DRD3—Parkinson's disease	0.000111	0.00128	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000107	0.00124	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—GRM4—Parkinson's disease	0.000107	0.00123	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000105	0.00121	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TH—Parkinson's disease	0.000102	0.00118	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000102	0.00118	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—PENK—Parkinson's disease	0.000101	0.00117	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—HTR7—Parkinson's disease	0.000101	0.00116	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP2D6—Parkinson's disease	9.97e-05	0.00115	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—DRD3—Parkinson's disease	9.81e-05	0.00113	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CTGF—Parkinson's disease	9.79e-05	0.00113	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	9.73e-05	0.00112	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	9.61e-05	0.00111	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	9.4e-05	0.00108	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—PDYN—Parkinson's disease	9.26e-05	0.00107	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP2E1—Parkinson's disease	9.12e-05	0.00105	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	9.1e-05	0.00105	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—NQO1—Parkinson's disease	9.02e-05	0.00104	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—TH—Parkinson's disease	8.89e-05	0.00103	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—DGKQ—Parkinson's disease	8.87e-05	0.00102	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	8.84e-05	0.00102	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—GRM5—Parkinson's disease	8.6e-05	0.000993	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYCS—Parkinson's disease	8.53e-05	0.000985	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	8.48e-05	0.000979	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	8.34e-05	0.000962	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	8.23e-05	0.00095	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	8.21e-05	0.000947	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—DGKQ—Parkinson's disease	8.06e-05	0.00093	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GPR37—Parkinson's disease	8.06e-05	0.00093	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	8.05e-05	0.000929	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	7.8e-05	0.0009	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—COMT—Parkinson's disease	7.56e-05	0.000872	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTP1—Parkinson's disease	7.52e-05	0.000868	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—MAOA—Parkinson's disease	7.5e-05	0.000866	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—HMOX1—Parkinson's disease	7.42e-05	0.000856	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	7.38e-05	0.000851	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PPP1R1B—Parkinson's disease	7.37e-05	0.000851	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—ADORA2A—Parkinson's disease	7.32e-05	0.000844	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ABCB1—Parkinson's disease	7.12e-05	0.000822	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	7.08e-05	0.000817	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	7.05e-05	0.000814	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	6.93e-05	0.0008	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTM1—Parkinson's disease	6.91e-05	0.000798	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.84e-05	0.000789	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GRK5—Parkinson's disease	6.73e-05	0.000776	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GPX1—Parkinson's disease	6.62e-05	0.000764	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—HTR1A—Parkinson's disease	6.35e-05	0.000732	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—TAC1—Parkinson's disease	6.25e-05	0.000721	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—DRD1—Parkinson's disease	6.13e-05	0.000707	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—MTHFR—Parkinson's disease	6.11e-05	0.000705	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GRK5—Parkinson's disease	6.11e-05	0.000705	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GRM4—Parkinson's disease	6.03e-05	0.000696	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—DRD3—Parkinson's disease	5.94e-05	0.000685	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	5.76e-05	0.000665	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	5.75e-05	0.000663	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VPS35—Parkinson's disease	5.75e-05	0.000663	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	5.72e-05	0.00066	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PENK—Parkinson's disease	5.72e-05	0.00066	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	5.71e-05	0.000658	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—APOE—Parkinson's disease	5.69e-05	0.000656	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	5.67e-05	0.000654	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	5.65e-05	0.000651	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	5.64e-05	0.000651	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GRM4—Parkinson's disease	5.48e-05	0.000632	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—HTR7—Parkinson's disease	5.37e-05	0.00062	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	5.26e-05	0.000606	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PDYN—Parkinson's disease	5.23e-05	0.000604	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PENK—Parkinson's disease	5.19e-05	0.000599	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	5.18e-05	0.000598	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	4.94e-05	0.00057	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GRM5—Parkinson's disease	4.86e-05	0.000561	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—INS—Parkinson's disease	4.86e-05	0.000561	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—DGKQ—Parkinson's disease	4.76e-05	0.000549	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GPR37—Parkinson's disease	4.76e-05	0.000549	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PDYN—Parkinson's disease	4.75e-05	0.000548	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GRM5—Parkinson's disease	4.42e-05	0.00051	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PPP1R1B—Parkinson's disease	4.35e-05	0.000502	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—EDN1—Parkinson's disease	4.3e-05	0.000496	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADORA2A—Parkinson's disease	4.13e-05	0.000477	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—MAPK8—Parkinson's disease	3.83e-05	0.000441	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RIT2—Parkinson's disease	3.81e-05	0.000439	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—HTR2A—Parkinson's disease	3.76e-05	0.000434	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADORA2A—Parkinson's disease	3.75e-05	0.000433	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	3.73e-05	0.00043	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ND3—Parkinson's disease	3.73e-05	0.00043	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GRK5—Parkinson's disease	3.61e-05	0.000416	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—HTR1A—Parkinson's disease	3.59e-05	0.000414	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—TAC1—Parkinson's disease	3.53e-05	0.000408	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—OMD—Parkinson's disease	3.5e-05	0.000404	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	3.5e-05	0.000404	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—DRD1—Parkinson's disease	3.46e-05	0.0004	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—DRD3—Parkinson's disease	3.36e-05	0.000387	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	3.32e-05	0.000383	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HTR1A—Parkinson's disease	3.26e-05	0.000376	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GRM4—Parkinson's disease	3.24e-05	0.000373	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—TAC1—Parkinson's disease	3.21e-05	0.00037	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GCH1—Parkinson's disease	3.17e-05	0.000366	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	3.15e-05	0.000363	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.13e-05	0.000362	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PENK—Parkinson's disease	3.07e-05	0.000354	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAG—Parkinson's disease	3.07e-05	0.000354	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	3.05e-05	0.000352	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	3.03e-05	0.00035	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	2.85e-05	0.000328	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GBA—Parkinson's disease	2.82e-05	0.000326	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.82e-05	0.000326	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—DBH—Parkinson's disease	2.82e-05	0.000326	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDYN—Parkinson's disease	2.81e-05	0.000324	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	2.76e-05	0.000318	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GFAP—Parkinson's disease	2.64e-05	0.000304	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GRM5—Parkinson's disease	2.61e-05	0.000301	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	2.44e-05	0.000282	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	2.43e-05	0.00028	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGF20—Parkinson's disease	2.29e-05	0.000264	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	2.22e-05	0.000256	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	2.21e-05	0.000255	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	2.13e-05	0.000245	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—DDC—Parkinson's disease	2.07e-05	0.000239	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—INSR—Parkinson's disease	2.05e-05	0.000236	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.96e-05	0.000226	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGB—Parkinson's disease	1.93e-05	0.000223	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	1.93e-05	0.000223	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	1.92e-05	0.000222	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TAC1—Parkinson's disease	1.9e-05	0.000219	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	1.86e-05	0.000214	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	1.8e-05	0.000208	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.76e-05	0.000203	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.74e-05	0.000201	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	1.68e-05	0.000194	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	1.63e-05	0.000188	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	1.36e-05	0.000157	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	1.32e-05	0.000152	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	1.3e-05	0.00015	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.27e-05	0.000147	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NGF—Parkinson's disease	1.2e-05	0.000138	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.19e-05	0.000137	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.17e-05	0.000135	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—TH—Parkinson's disease	1.16e-05	0.000133	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	1.14e-05	0.000132	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.11e-05	0.000128	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APOE—Parkinson's disease	1.06e-05	0.000122	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—COMT—Parkinson's disease	9.83e-06	0.000113	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	9.78e-06	0.000113	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MAOA—Parkinson's disease	9.76e-06	0.000113	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	9.65e-06	0.000111	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	9.26e-06	0.000107	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—INS—Parkinson's disease	9.06e-06	0.000104	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	8.99e-06	0.000104	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GPX1—Parkinson's disease	8.61e-06	9.93e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	7.94e-06	9.17e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—APOE—Parkinson's disease	7.39e-06	8.53e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	6.74e-06	7.78e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	6.7e-06	7.73e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—INS—Parkinson's disease	6.32e-06	7.29e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	6.2e-06	7.15e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL6—Parkinson's disease	3.96e-06	4.57e-05	CbGpPWpGaD
